Top searches

PL

Resources

B2RLaw advises Proteon Pharmaceuticals on a strategic partnership with Skretting

01/02/2021

B2RLaw has advised Proteon Pharmaceuticals on a strategic partnership with Skretting aimed at providing functional solutions to tackle health challenges in the aquaculture industry.

The companies will collaborate on developing products using bacteriophage technology to support aquaculture farmers as part of a holistic health strategy. The companies will work in a parallel R&D pipeline on the project.

The Partnership allows Proteon to grow its product portfolio in aquaculture and expand its presence worldwide. Both Proteon Pharmaceuticals and Skretting predict that the technology will become a valuable component of integrated management strategies on-farm with both feed and water applications under investigation.

Proteon Pharmaceuticals is a Polish originating biotech company with a vision to develop natural feed additives that help remove antibiotics from the food chain and improve animal and human health. The Company uses precision biology for microbiome protection to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.

Norwegian company, Skretting is the world’s largest producer of feeds for farmed fish. The Company has operations on five continents and produces 2.5 million tonnes of feed annually, for more than sixty species of fish. Skretting has 3,500 employees worldwide. Skretting has an R&D unit known as Skretting Aquaculture Research Centre (ARC) with the main objective to provide research and technical support regarding fish and shrimp feed. It has 140 employees representing 25 nationalities.

B2RLaw’s team advising Proteon Pharmaceuticals was led by Partner George Havaris and included Counsels Paulina Wyrostek and Malwina Niczke – Chmura.

George Havaris advises, “Proteon Pharmaceuticals is a Polish company that is well on the path to being a global leader in its field of operation. Animal health is a little-known industry in the wider public eye. However, animal health is fundamental to the health and well-being of humans. We congratulate Proteon and Skretting on this exciting Partnership and we look forward to continuing our support to Proteon on its growth path”.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

27/03/2025

B2RLaw recommended in the Legal 500 EMEA ranking 2025

This year we made it to the prestigious Top Tier 1 White-collar crime in Poland! Other distinguished practices: Construction, Private […]

MORE
25/03/2025

B2RLaw in Chambers & Partners Europe 2025 ranking!

B2RLaw has been recognized by Chambers and Partners Europe 2025! Bartłomiej Jankowski – Band 2 Lawyer in White-Collar Crime & Corporate Investigations […]

MORE
27/02/2025

B2RLaw in Chambers & Partners Global 2025 ranking!

B2RLaw has been recognized by Chambers and Partners Global 2025 in the category Corporate/M&A: Mid-Market! This is the success of the entire corporate […]

MORE
25/02/2025

B2RLaw at REassurance Padel Cup 2025

The long-awaited REassurance Padel Cup 2 is back! Following the huge success of our first event a year ago, we […]

MORE
17/12/2024

European Commission Report ”VAT AFTER VIDA” REFLECTIONS ON THE FUTURE OF VAT

What changes in the VAT Directive should be taken into consideration by the new European Commission?  What is the vision […]

MORE
13/12/2024

B2RLaw develops recommendations for future EU VAT changes

The 38th plenary meeting of the VAT Expert Group (VEG) began a few hours ago in Brussels. During today’s meeting, […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close